CENTENE CORPORATION (CNC) — financial distillation
Annual history (10-K)
Quarterly history (10-Q)
Two headline lines are shown to start. Click any item in a legend to add or remove it — every figure on the chart is one the table below also carries, for the period it names.
In brief, from the full filed history
- Revenue grew from $3.36B (period ending 2008-12-31) to $174.58B (period ending 2025-12-31) — a 26.2% annual pace across 17 year(s) of filed history.
- Net margin turned from a 2.5% margin to a loss (-3.8%) over that same span.
- Across 52 tracked quarters, the strongest was $44.90B (quarter ending 2025-09-30) and the weakest was $1.04B (quarter ending 2009-09-30).
Annual — most recent 10-K
| Line | Value | Period ends | Form | Filing |
|---|---|---|---|---|
| Revenue | $174.58B | 2025-12-31 | 10-K | 0001071739-26-000049 |
| Gross profit | $14.21B | 2025-12-31 | 10-K | 0001071739-26-000049 |
| Operating income | $-7.62B | 2025-12-31 | 10-K | 0001071739-26-000049 |
| Net income | $-6.67B | 2025-12-31 | 10-K | 0001071739-26-000049 |
| Diluted EPS | $-13.53 | 2025-12-31 | 10-K | 0001071739-26-000049 |
| Total assets | $76.75B | 2025-12-31 | 10-K | 0001071739-26-000049 |
| Total liabilities | $56.69B | 2025-12-31 | 10-K | 0001071739-26-000049 |
| Cash & equivalents | $17.89B | 2025-12-31 | 10-K | 0001071739-26-000049 |
| Operating cash flow | $5.09B | 2025-12-31 | 10-K | 0001071739-26-000049 |
Quarterly — most recent 10-Q
| Line | Value | Period ends | Form | Filing |
|---|---|---|---|---|
| Revenue | $44.38B | 2026-06-30 | 10-Q | 0001071739-26-000153 |
| Gross profit | $4.62B | 2026-06-30 | 10-Q | 0001071739-26-000153 |
| Operating income | $1.20B | 2026-06-30 | 10-Q | 0001071739-26-000153 |
| Net income | $1.09B | 2026-06-30 | 10-Q | 0001071739-26-000153 |
| Diluted EPS | $2.19 | 2026-06-30 | 10-Q | 0001071739-26-000153 |
| Total assets | $83.01B | 2026-06-30 | 10-Q | 0001071739-26-000153 |
| Total liabilities | $60.35B | 2026-06-30 | 10-Q | 0001071739-26-000153 |
| Cash & equivalents | $24.15B | 2026-06-30 | 10-Q | 0001071739-26-000153 |
| Operating cash flow | $4.37B | 2026-03-31 | 10-Q | 0001071739-26-000098 |
Reading
The figures above are taken directly from filings with the U.S. Securities and Exchange Commission. The reading below was generated by a local language model from only those figures; it introduces no numbers of its own. It is not investment advice.
Centene Corporation’s business scale is substantial, with revenues surging from $3.36 billion in 2008 to a staggering $174.58 billion by the end of 2025, reflecting an impressive 26.2% annual growth rate over 17 years. This rapid expansion underscores the company’s significant market presence and growing influence in the healthcare sector. However, despite this robust revenue growth, net income has transitioned from a positive margin of 2.5% to a loss of -3.8%, indicating operational challenges in translating revenue into profitability.
The multi-year trajectory reveals periods of substantial growth interspersed with fluctuations in profitability. Notably, the company’s net income turned negative in 2025, marking a significant shift from prior years’ positive earnings. This trend warrants close observation in future filings to discern whether this is a temporary setback or indicative of deeper structural issues. Investors should monitor the company’s ability to manage costs and improve operational efficiency to reverse the negative net income trend and sustain long-term profitability.
Source: SEC EDGAR company facts for CIK 0001071739 · filings index